CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS
Application
US20260083754A1
Kind: A1
Mar 26, 2026
Inventors
Michael A. GOSSELIN, Jin-Wang LAI, Gopi M. VENKATESH
Abstract
The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention as orally disintegrating tablets comprising a topically active corticosteroid adsorbed onto a pharmaceutically acceptable carrier such as silicified microcrystalline cellulose.
CPC Classifications
A61K 31/56
A61J 3/10
A61K 9/0056
A61K 9/2009
A61K 9/2018
A61K 9/2027
A61K 9/2054
A61K 9/2081
A61K 9/2095
A61K 45/06
B29C 43/003
B29C 43/006
Filing Date
2025-11-28
Application No.
19403674